Evidence map›Paper›PMID 22623595›Full record

ArticleJournal of the National Cancer Institute. Monographs2012

Time issues in multilevel interventions for cancer treatment and prevention.

Jeffrey Alexander, Irene Prabhu Das, Timothy P Johnson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the National Cancer Institute. Monographs, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Multilevel factors affecting quality: examples from the cancer care continuum.Journal of the National Cancer Institute. Monographs · 2012
    Article
  8. Multilevel intervention research: lessons learned and pathways forward.Journal of the National Cancer Institute. Monographs · 2012
    Article
  9. Health reforms as examples of multilevel interventions in cancer care.Journal of the National Cancer Institute. Monographs · 2012
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeffrey AlexanderDepartment of Health Management and Policy, The University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. jalexand@umich.edu
Irene Prabhu Das
Timothy P Johnson
University of Illinois Chicago · USUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of time introduces important complexities in estimating intervention effects, program and evaluation design, and measurement and analysis of individual change in multilevel interventions (MLIs). Despite growing recognition that time is a critical element for assessing both individual-level outcomes and higher-level changes in organizational, community, and policy contexts, most MLI designs and evaluations have not addressed these issues. In this chapter we discuss 1) conceptualizing disease life-course and treatment theory in MLIs, 2) approaches to incorporating time in research and program design for MLIs in cancer treatment and prevention, 3) analysis of time-varying multilevel data in the context of cancer treatment and prevention, and 4) resource considerations and trade-offs of incorporating time as a dimension of MLIs and analysis. Although analytic techniques for analyzing time-related phenomena are becoming more available and powerful, there has not been corresponding progress made in the development of theory to guide the application of these techniques in program design and implementation.

Indexed as

Continuity of Patient CareDelivery of Health Care, IntegratedPatient Care TeamPatient-Centered CareQuality of Health CareTimeCombined Modality TherapyHealth Services ResearchHumansNeoplasmsOrganizational InnovationResearch DesignTime FactorsUnited States

Identifiers

PMID22623595
PMCPMC3482974
OpenAlexW2108179483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.